HIGHLIGHTS
- who: Monica Palanichamy Kala from the Program in Emerging Infectious Diseases, Duke-National University of Singapore NC, USA have published the Article: Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines, in the Journal: (JOURNAL)
- what: The current standard of care for dengue remains supportive care.
SUMMARY
The authors describe both direct-acting and host factors-targeting antivirals that show the Pre-clinical data Clinical data JNJ-64281802 NS4B inhibitor that inhibits viral_replication Antiviral activity in_vitro was shown for its Clinical trials for dengue prophylaxis in analog, JNJ-A07. Ivermectin Antiviral . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.